Study of ICG Fluorescence Imaging in Open Fracture and Infection Patients

RecruitingOBSERVATIONAL
Enrollment

10

Participants

Timeline

Start Date

June 10, 2025

Primary Completion Date

June 10, 2026

Study Completion Date

June 10, 2027

Conditions
Fractures, BoneTrauma Injury
Interventions
DRUG

Immunofluorescence Imaging

Patients will be administered FDA approved ICG through intravenous injection and imaged by a FDA approved surgical microscope (Spy Elite) which is 0.5 meter away from the subject. Both ICG fluorescence and the two imaging systems have been used for routine clinical practice for many years. Figure (a) shows the Schematic sketch of the imaging systems. ICG fluorescence imaging utilizes intravenously injected ICG, which is a fluorescent dye that is FDA-approved for clinical use, illuminated with near-infrared light. The ICG dye is indirectly activated and the dynamic fluorescence due to bone perfusion can be captured by a video rate imaging system.

Trial Locations (1)

03756

RECRUITING

Dartmouth-Hitchcock Medical Center, Lebanon

All Listed Sponsors
collaborator

Dartmouth College

OTHER

lead

Dartmouth-Hitchcock Medical Center

OTHER

NCT06793644 - Study of ICG Fluorescence Imaging in Open Fracture and Infection Patients | Biotech Hunter | Biotech Hunter